Clinical Trial Update: Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating maintenance therapy with rucaparib after bevacizumab maintenance following carboplatin-based first-line chemotherapy in ovarian,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Carcinoma of the Ovary
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Rucaparib (rucaparib)

Snippet

Sponsor: North Eastern German Society of Gynaecological Oncology | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Status: COMPLETED